| Melody Stone, MD | |
|
1419 Village Dr, Saint Joseph, MO 64506-2459 | |
| (816) 364-1507 | |
| Not Available |
| Full Name | Melody Stone |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 26 Years |
| Location | 1419 Village Dr, Saint Joseph, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558337196 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Harrison County Community Hospital | Bethany, MO | Hospital |
| Shenandoah Medical Center | Shenandoah, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Melody L Stone Md Pa | 5496854374 | 5 |
| Melody L Stone Md Pa | 5496854374 | 5 |
| Melody L Stone Md Pa | 5496854374 | 5 |
News Archive
Oncimmune LLC, maker of EarlyCDT-Lung, a simple blood test that aids physicians in risk assessment and the early detection of lung cancer, today announced validation study results demonstrating the diagnostic and economic benefits of a standardized and reproducible autoantibody laboratory test that may significantly improve the prognosis for lung cancer patients.
Methicillin-resistant Staphylococcus aureus (MRSA) infections are caused by a type of staph bacteria that has become resistant to the antibiotics used to treat ordinary staph infections.
RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today announced the company's new focused RNAi therapeutic strategy at the Jefferies 2010 Global Life Sciences Conference.
Enzo Biochem, Inc. today reported results for the fiscal fourth quarter, consistent with our announcement on September 20, 2010, and for the year ended July 31, 2010.
› Verified 4 days ago
| Entity Name | Melody L Stone Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740358159 PECOS PAC ID: 5496854374 Enrollment ID: O20181106000563 |
News Archive
Oncimmune LLC, maker of EarlyCDT-Lung, a simple blood test that aids physicians in risk assessment and the early detection of lung cancer, today announced validation study results demonstrating the diagnostic and economic benefits of a standardized and reproducible autoantibody laboratory test that may significantly improve the prognosis for lung cancer patients.
Methicillin-resistant Staphylococcus aureus (MRSA) infections are caused by a type of staph bacteria that has become resistant to the antibiotics used to treat ordinary staph infections.
RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today announced the company's new focused RNAi therapeutic strategy at the Jefferies 2010 Global Life Sciences Conference.
Enzo Biochem, Inc. today reported results for the fiscal fourth quarter, consistent with our announcement on September 20, 2010, and for the year ended July 31, 2010.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melody Stone, MD 1419 Village Dr, Saint Joseph, MO 64506-2459 Ph: (816) 364-1507 | Melody Stone, MD 1419 Village Dr, Saint Joseph, MO 64506-2459 Ph: (816) 364-1507 |
News Archive
Oncimmune LLC, maker of EarlyCDT-Lung, a simple blood test that aids physicians in risk assessment and the early detection of lung cancer, today announced validation study results demonstrating the diagnostic and economic benefits of a standardized and reproducible autoantibody laboratory test that may significantly improve the prognosis for lung cancer patients.
Methicillin-resistant Staphylococcus aureus (MRSA) infections are caused by a type of staph bacteria that has become resistant to the antibiotics used to treat ordinary staph infections.
RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today announced the company's new focused RNAi therapeutic strategy at the Jefferies 2010 Global Life Sciences Conference.
Enzo Biochem, Inc. today reported results for the fiscal fourth quarter, consistent with our announcement on September 20, 2010, and for the year ended July 31, 2010.
› Verified 4 days ago
Isadore Tarantino, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5204 N Belt Hwy, Saint Joseph, MO 64506 Phone: 816-383-8180 Fax: 816-233-3983 | |
Dr. Ana Marie Liolios, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5204 N Belt Hwy, Plastic Surgery And Dermatology, Saint Joseph, MO 64506 Phone: 816-383-8180 | |
Dr. Richard Joseph Walsh, MD Dermatology Medicare: May Accept Medicare Assignments Practice Location: 3917 Sherman Avenue, Saint Joseph, MO 64506 Phone: 816-364-6777 |